Inventor
Igor Rukhman
Inventor
Haifa, IL
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes18%
C07BGeneral methods of organic chemistry3%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07HSugars3%
PatentTitleYear
10,829,509Pure heptasulfated disaccharides having improved oral bioavailability20209,744,151'Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol'20179,675,581'Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinol'20179,278,083'Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol'20168,937,097'Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol'20158,383,842'Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol'20137,947,740'Bimatoprost crystalline form I'20117,838,683'Synthesis of irbesartan'20107,378,531'Process for the preparation of valsartan'20087,332,612'Amorphous and crystalline forms of losartan potassium and process for their preparation'20087,312,340'Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one'20077,301,035'Intermediates for the synthesis of irbesartan'20077,227,026'Synthesis of irbesartan'20077,217,825'Synthesis of irbesartan'20077,199,144'Process for the preparation of valsartan and intermediates thereof'20077,105,557'Polymorphs of valsartan'20067,038,060'Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one'20067,019,148'Synthesis of irbesartan'20066,958,398'Methods for making thebaine or its acid salts'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005Patents assigned to EURO CELTIQUE SA (1)· patent assignee history
2005–2011Based in Haifa, IL· patent location history
2006–2010Patents assigned to TEVA PHARMA (11)· patent assignee history
2006–2008Based in Technion, IL· patent location history
2013–2015Patents assigned to PURDUE PHARMA LP (2)· patent assignee history
2013Patents assigned to ETINGER MARINA (1)· patent assignee history
2013–2020Based in Yokneam, IL· patent location history
2016–2017Patents assigned to SVC PHARMA LP (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TEVA PHARMA | 11 | 2006–2010 |
| SVC PHARMA LP | 3 | 2016–2017 |
| PURDUE PHARMA LP | 2 | 2013–2015 |
| ETINGER MARINA | 1 | 2013 |
| EURO CELTIQUE SA | 1 | 2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Haifa, IL | 9 | 2005–2011 |
| Yokneam, IL | 6 | 2013–2020 |
| Technion, IL | 4 | 2006–2008 |